|
MISSION
To provide excellence in delivering health care products and solutions, both proactive and preventative, with a focus on increased patient health and safety.
COMPANY OVERVIEW
RyMed Technologies, Inc., founded in 1994, specializes in the development and marketing of innovative safety products in the field of intravenous catheter care management.
With patented technology, RyMed has set a new industry standard with its InVision-Plus® Neutral® I.V. Connector System designed to reduce the possibility of Intraluminal Thrombotic Catheter Occlusions as well as reduce the possibility of Intraluminal Catheter-related Bloodstream Infections. The InVision-Plus® Neutral® is the first neutral movement injection port developed in the medical field.
The InVision-Plus® Neutral® has widespread applications in virtually all hospitals, care centers, in-home services and doctor offices where I.V. catheter therapies are implemented. The products’ universal fit properties and ease of operation provide institutions and individual users with maximum opportunity to employ the InVision-Plus® Neutral® Connector System.
PRINCIPALS
Dana Wm. Ryan is a Director and Chairman of the Board of Directors of the Company. Mr. Ryan also holds the positions of President and Chief Executive Officer. Mr. Ryan has 33 years of experience in the disposable I.V. and O.R. medical device industry with Johnson & Johnson, Deseret Medical, Ryan Medical, Symbiosis and RyMed Technologies Inc. He is recognized as being one of the pioneers in “safety-oriented” medical product design, with over 35 patents to date worldwide to his credit.
James M. Kaiser is a Director of the Company and holds the position of Vice-President of Operations. Mr. Kaiser brings to RyMed over 33 years experience in the high volume, disposable medical devices in the areas of manufacturing, regulatory affairs, quality control & assurance, and sterilization; Cutter Labs, Deseret Medical, HealthTech, Ryan Medical, Isomedix (Steris) and RyMed Technologies, Inc.
|
